PU6HA
Asset Logo

Pepper Sparkz Trust No.6

πŸ‡¦πŸ‡Ί ASX

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

N/A
Annual Growth

5 years average annual growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

0
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Class A1-A Frn Mat 16-Mar-2032 Min Cons $5Ht Nc

πŸ“ˆ Performance

Price History

N/A

1M

All Time

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in PU6HA

0

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

N/A

πŸ’΅ Average investment amount

N/A

⏰ Last time a customer invested in PU6HA

N/A
PU6HA investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

πŸ‘Ά Age of investors

18 - 25

26 - 34

35 - 90

πŸ™‹ Legal gender of investors

Female

Male

Pearlers who invest in PU6HA also invest in...

Want more shares? Try these...

Pepper Sparkz Trust No.6

PU6HB

Find Out More

Petratherm Ltd. engages in the development of mineral exploration projects. The company is headquartered in Adelaide, South Australia. The company went IPO on 2004-07-27. The Company’s projects include Mabel Creek Iron-Oxide Copper-Gold, Comet Gold, Comet Rare Earth, Muckanippie, and Woomera and Arcoona Iron-Oxide Copper-Gold (IOCG). The Mabel Creek Project, located approximately 50 kilometers (km) northeast of Coober Pedy in South Australia, is prospective for IOCG and Broken Hill Type (BHT) lead-zinc-silver (Pb-Zn-Ag) mineralization. The Comet Project holds a ground position totaling approximately 1,915 kilometers (km2) in the Northern Gawler Craton of South Australia. The Project consists of exploration license (EL) 6443, EL6633, EL6722, EL6816 and EL6818. The Muckanippie Project comprises two tenements (EL6855 and EL6815) totaling approximately 258 km2 over the central and outer portions of Muckanippie Anorthosite Complex. The Woomera and Arcoona IOCG Project has a landholding of approximately 668 km2 and is located in the province of South Australia.

πŸ™Œ Performance (5Yr p.a)

11.85%

πŸ“Š Share price

$0.05 AUD

⛏️ MINING

πŸ“ˆ HIGH PRICE GROWTH

Prescient Therapeutics Ltd. is a biopharmaceutical company, which engages in the discovery and development of novel immunotherapeutic products for the treatment of chronic infectious diseases and cancer. The company is headquartered in South Melbourne, Victoria. The firm is developing personalized medicine approaches to cancer, including targeted and cellular therapies. Its product pipeline includes PTX-100, PTX-200, OmniCAR, CellPryme-M and CellPryme-A. PTX-100 has completed Phase Ib expansion cohort study in relapsed and refractory T cell lymphomas. PTX-200 is a PH domain inhibitor that inhibits a tumor survival pathway, Akt. OmniCAR is a universal immune receptor platform being developed to enable controllable T-cell activity and multi-antigen targeting with a single-cell product. CellPryme-M technology enhances adoptive cell therapy performance by shifting T and NK cells towards a central memory phenotype, improving persistence, and increasing the ability to find and penetrate tumors. CellPryme-A is an adjuvant therapy designed to be administered to patients alongside cellular immunotherapy to help them overcome a suppressive tumor microenvironment.

πŸ™Œ Performance (5Yr p.a)

-3.60%

πŸ“Š Share price

$0.04 AUD

🧬 BIOTECHNOLOGY

Compare
Add to watchlist